CURE Pharmaceutical Q3 Revenue Grows 58.9% Sequentially To $1.8M – CURE Pharmaceutical Hldg (OTC:CURR)
CURE Pharmaceutical Holding Corp. CURR revenue in the third quarter increased 32.1% year-over-year and 58.9% sequentially from Q2 2022 to $1.8 million. Q3 2022 Financial Highlights Gross profit…